Lung Cancer Screening Market Emerging Growth Analysis, Future Demand and Business Opportunities 2030

The "Lung Cancer Screening Market" size is expected to grow from US$ 2,326.5 million in 2022 to US$ 4,363.95 million by 2030; it is estimated to record a CAGR of 8.2% from 2022 to 2030.

The lung cancer screening market growth is attributed to the rising lung cancer Incidence and increasing government support. However, the high cost of lung screening tests is hampering the growth of the lung cancer screening market.
Lung cancer screening is a process used to detect lung cancer in otherwise healthy people with a high risk of lung cancer. Lung cancer screening is recommended for older adults who are long time smokers and who don't have any signs or symptoms of lung cancer. Doctors use a LDCT scan of the lungs to look for lung cancer. If lung cancer is detected early, it's more likely to be cured with treatment.

Get Exclusive Sample Pages of This Report @: https://www.premiummarketinsights.com/sample/TIP00073849?utm_source=OpenPr&utm_medium=10688

Companies Profiled in this report includes:

• Intelerad Medical Systems Incorporated
• Nuance Communications Inc
• GE HealthCare Technologies Inc
• Medtronic Plc
• Canon Medical Systems Corp
• Koninklijke Philips NV
• Siemens AG
• CVS Health
• bioAffinity Technologies, Inc.
• LungLife AI, Inc.

Rising Government Supportis Boosting The Growth Of The Lung Cancer Screening Market

The United States Preventive Services Task Force recommends people aged 55-80 with a 30-pack-year (equivalent to smoking 20 cigarettes per day for 30 years) smoking history who are presently smoking or have quit within the last 15 years to undergo annual low-dose computed tomography (LDCT) screening for lung cancer.

As per the Cancer Australia 2023 report, lung cancer is the most common form of cancer in Australia, accounting for the majority of the mortality rates. Furthermore, early detection of lung cancer helps improve survival rates. Also, the new screening program will help detect lung cancer during the early stages when treatment is not likely to be successful. For example, in July 2021, Cancer Australia partnered with the Department of Health and Aged Care to determine the feasibility of a lung cancer screening program in Australia.

Get Full Report here @: https://www.premiummarketinsights.com/reports-tip/lung-cancer-screening-market

Lung Cancer Screening Market Segmentation:

By Cancer Type:
• Non-Small Cell Lung Cancer (NSCLC)
• Small Cell Lung Cancer

By Technology:
• Low-Dose Computed Tomography (LDCT)
• Chest X-ray
• Liquid Biopsy

By Age Group:
• & Older
• Below 50

By End User:
• Hospitals
• Diagnostic Centers

Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the lung cancer screening market. A few recent key market developments are listed below:
In November 2021, GE Healthcare and Optellum collaborated to advance precision diagnosis and treatment of lung cancer. Together, the companies are seeking to address one of the largest challenges in diagnosing lung cancer, helping providers to determine the malignancy of a lung nodule: a suspicious lesion that may be benign or cancerous.

In June 2022, Royal Philips teamed up with Biodesix, Inc. to incorporate the results of Biodesix?s Nodify Lung blood-based lung nodule risk assessment testing into Philips Lung Cancer Orchestrator lung cancer patient management system. The incorporation of proteomics data - along with the radiologic and patient history data currently used to determine treatment decisions can help create diagnostic efficiency for cancer care centers in the management of a growing number of lung nodule cases via the contextual launch of Biodesix Nodify Lung application within Lung Cancer Orchestrator.

Buy this research report @: https://www.premiummarketinsights.com/buy/TIP00073849?utm_source=OpenPr&utm_medium=10688

Contact Us:

If you have any queries about this report or if you would like further information, please
Contact Person: Ankit Mathur
Phone: +1-646-491-9876
Email: sales@premiummarketinsights.com

About Us:

Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost-effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.
We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.

This release was published on openPR.